Mr. Sarabia is a trained mechanical engineer that brings +23 years of experience in product development, product launch, sales, market development, entrepreneurship, corporate formation, & venture funding. He designed and developed Evalve’s MitraClip Device and is listed as an inventor on 16 MitraClip patents. Mr. Sarabia founded 510 Kardiac Devices, Inc., which was acquired by Keystone Heart, a Venus Medtech subsidiary in 2020.

Mr. Liao brings 23 years of experience in the medical device industry developing catheters and delivery systems. He held engineering positions at CardiAQ Valve Technologies, Abbott Vascular (Evalve, Inc.), Boston Scientific, and Medtronic. He holds 13 patents related to the CardiAQ/MitraClip devices. Mr. Liao served as an early engineer at CardiAQ Valve Technologies, acquired by Edwards Lifesciences, leading the development of their TMVR device.

Mr. Raschdorf brings 22 years of experience, with roles in product development, training, clinical trial launch, product launch, sales and market development specializing in medical devices. He is an inventor on 24 MitraClip patents. He served as Country Manager of MitraClip in Italy, as well as Market Development Manager. Mr. Raschdorf served as the Global Vice President of Therapy Development at Caisson Interventional.

Dr. Rajagopal is a practicing cardiologist in Atlanta, GA specializing in interventional cardiology. He is board-certified in internal medicine, cardiovascular medicine, nuclear cardiology, and interventional cardiology. Dr. Rajagopal has a special interest and expertise in the minimally invasive treatment of valve disease. He is also currently the Co-Medical Director of Marcus Heart Valve Center at Piedmont Heart Institute.